Stock Buybacks (Quarterly) Chart

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 -2.179M
March 31, 2026 50.04M
December 31, 2025 46.53M
September 30, 2025 50.03M
June 30, 2025 48.47M
March 31, 2025 0.00
December 31, 2024 -0.934M
September 30, 2024 0.00
June 30, 2024 23.64M
March 31, 2024 0.00
December 31, 2023 -1.139M
September 30, 2023 -0.025M
June 30, 2023 -3.253M
March 31, 2023 -0.333M
December 31, 2022 -2.039M
September 30, 2022 -1.60M
June 30, 2022 -12.68M
March 31, 2022 -11.02M
December 31, 2021 -6.032M
September 30, 2021 -3.052M
June 30, 2021 -7.246M
March 31, 2021 -10.32M
December 31, 2020 -10.36M
September 30, 2020 -29.63M
June 30, 2020 -4.319M
Date Value
March 31, 2020 -3.455M
December 31, 2019 -4.61M
September 30, 2019 -1.423M
June 30, 2019 -3.737M
March 31, 2019 -1.101M
December 31, 2018 -3.528M
September 30, 2018 -2.982M
June 30, 2018 -2.025M
March 31, 2018 -0.419M
December 31, 2017 -2.28M
September 30, 2017 -2.691M
June 30, 2017 -2.817M
March 31, 2017 -0.852M
December 31, 2016 -1.07M
September 30, 2016 -0.769M
June 30, 2016 -2.385M
March 31, 2016 -3.041M
December 31, 2015 -2.173M
September 30, 2015 -1.823M
June 30, 2015 -4.123M
March 31, 2015 -4.047M
December 31, 2014 -2.736M
September 30, 2014 -2.381M
June 30, 2014 -111.79M
March 31, 2014 -1.964M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 149.30M
Liquidia Corp. -1.443M
Organon & Co. 0.00
ANI Pharmaceuticals, Inc. 0.505M
Corcept Therapeutics, Inc. -9.42M